HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M M Samama Selected Research
M M Samama Research Topics
Disease
9
Venous Thromboembolism
06/2011 - 07/2000
5
Thrombocytopenia (Thrombopenia)
02/2011 - 05/2000
4
Hemorrhage
10/2013 - 02/2002
4
Thrombosis (Thrombus)
02/2011 - 03/2000
3
Atrial Fibrillation
10/2013 - 02/2011
3
Venous Thrombosis (Deep-Vein Thrombosis)
11/2005 - 10/2001
3
Neoplasms (Cancer)
03/2005 - 11/2000
2
Thrombophilia
11/2005 - 06/2002
2
Activated Protein C Resistance (APC Resistance)
07/2002 - 01/2001
1
Stroke (Strokes)
06/2011
1
Acute Coronary Syndrome
02/2011
1
von Willebrand Diseases (von Willebrand's Disease)
04/2006
1
Congenital Abnormalities (Deformity)
03/2005
1
Coronary Thrombosis
11/2002
1
Body Weight (Weight, Body)
06/2002
1
Postoperative Pain
02/2002
1
Acute Kidney Injury (Acute Renal Failure)
02/2002
1
Hypersensitivity (Allergy)
02/2002
1
Pain (Aches)
02/2002
1
Inflammation (Inflammations)
01/2001
1
Thrombocytosis (Thrombocythemia)
01/2001
1
Heart Failure
12/2000
1
Venous Insufficiency
12/2000
1
Obesity
12/2000
1
Communicable Diseases (Infectious Diseases)
12/2000
1
Hematologic Neoplasms (Hematological Malignancy)
12/2000
1
Wounds and Injuries (Trauma)
12/2000
1
Myocardial Infarction
07/2000
Drug/Important Bio-Agent (IBA)
8
Anticoagulants
IBA
10/2013 - 09/2001
5
Heparin (Liquaemin)
FDA Link
Generic
02/2011 - 05/2000
3
Thrombin
FDA Link
10/2013 - 01/2001
2
Pharmaceutical Preparations
IBA
10/2013 - 12/2000
2
fibrin fragment D (D-dimer)
IBA
11/2005 - 12/2003
2
Biological Products
IBA
03/2005 - 11/2000
1
Factor IIa
IBA
10/2013
1
N(4)-oleylcytosine arabinoside
IBA
10/2013
1
Rivaroxaban
IBA
10/2013
1
Dabigatran
FDA Link
10/2013
1
Factor Xa Inhibitors
IBA
10/2013
1
edoxaban
IBA
06/2011
1
Factor Xa (Coagulation Factor Xa)
IBA
06/2011
1
Ristocetin
IBA
04/2006
1
Factor VIII (Coagulation Factor VIII)
IBA
04/2006
1
von Willebrand Factor
IBA
04/2006
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
03/2005
1
Vitamin K
FDA Link
03/2005
1
Dalteparin (Dalteparin Sodium)
FDA Link
03/2005
1
Biomarkers (Surrogate Marker)
IBA
11/2002
1
Protein C
IBA
07/2002
1
Prothrombin (Factor II)
IBA
07/2002
1
factor V Leiden
IBA
07/2002
1
Ketoprofen (Orudis)
FDA Link
Generic
02/2002
1
Diclofenac (SR 38)
FDA Link
Generic
02/2002
1
Ketorolac
IBA
02/2002
1
Antibodies
IBA
10/2001
1
Platelet Factor 4
IBA
10/2001
1
Thromboplastin (Tissue Factor)
IBA
01/2001
1
Fibrin Fibrinogen Degradation Products
IBA
01/2001
1
cancer procoagulant
IBA
01/2001
1
Antiphospholipid Antibodies
IBA
01/2001
1
Fibrinopeptide A
IBA
01/2001
1
lipoprotein-associated coagulation inhibitor (TFPI)
IBA
01/2001
1
Fibrinogen (Factor I)
FDA Link
01/2001
1
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2001
1
Antithrombins
IBA
01/2001
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
03/2000
Therapy/Procedure
2
Therapeutics
11/2005 - 07/2000
2
Orthopedic Procedures
03/2005 - 11/2004
2
Duration of Therapy
06/2002 - 02/2002
1
Subcutaneous Injections
06/2002
1
Secondary Prevention
10/2001
1
Surgical Casts (Plaster Cast)
12/2000
1
Operative Surgical Procedures
07/2000